Constellation Brands, Inc. (NYSE:STZ) Surpasses Earnings Estimates Amid Legal Challenges

Posted Apr 9 by Two Blokes

Constellation Brands, Inc. (NYSE:STZ) reported earnings per share of $2.29, beating estimates and showcasing

Source: Two Blokes Trading

BlackRock Inc. (NYSE:BLK) Quarterly Earnings Preview

Posted Apr 9 by Two Blokes

BlackRock is set to release its quarterly earnings on April 11, 2025, with an estimated EPS of $10.69 and pro

Source: Two Blokes Trading

Walgreens Boots Alliance's Q2 2025 Earnings Overview

Posted Apr 9 by Two Blokes

Walgreens reported an earnings per share (EPS) of -$3.30, missing the estimated $0.32, but achieved revenue o

Source: Two Blokes Trading

Netflix, Inc. (NASDAQ:NFLX): A Potential Buying Opportunity Amid Recent Decline

Posted Apr 9 by Two Blokes

Netflix, Inc. (NASDAQ:NFLX) has experienced a slight decline of approximately 2.76% over the past month, pres

Source: Two Blokes Trading

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Earnings Report Highlights

Posted Apr 9 by Two Blokes

Earnings Per Share (EPS) of -$0.67, surpassing the estimated -$0.72. Reported revenue of approximately $18.45

Source: Two Blokes Trading

Delta Air Lines' Financial Performance and Market Position

Posted Apr 9 by Two Blokes

Earnings Per Share (EPS) of $0.46, surpassing estimates and indicating operational efficiency. Revenue reache

Source: Two Blokes Trading

Tariffs and Promotions Cloud Apple’s Margin Outlook, Says MoffettNathanson

Posted Apr 8 by Two Blokes

MoffettNathanson is maintaining its Sell rating on Apple (NASDAQ:AAPL) with a $184 price target, citing growin

Source: Two Blokes Trading

Morgan Stanley Names Netflix Its New Favorite in Media, Ditching Disney

Posted Apr 8 by Two Blokes

Morgan Stanley named Netflix (NASDAQ:NFLX) its new top pick in the media and entertainment sector, replacing D

Source: Two Blokes Trading

UBS Slashes Caterpillar Price Target, Warns of Deeper Earnings Risk

Posted Apr 8 by Two Blokes

UBS reaffirmed its Sell rating on Caterpillar (NYSE:CAT) while significantly lowering its price target to $243

Source: Two Blokes Trading

Blue Owl Capital Maintains Buy Rating at TD Cowen Amid Market Pullback

Posted Apr 8 by Two Blokes

TD Cowen reaffirmed a Buy rating on Blue Owl Capital (NYSE:OWL), maintaining a $30 price target, citing long-t

Source: Two Blokes Trading

Ocular Therapeutix Gets Bullish Coverage at William Blair

Posted Apr 8 by Two Blokes

William Blair initiated coverage on Ocular Therapeutix (NASDAQ:OCUL) with an Outperform rating, setting a fair

Source: Two Blokes Trading

UBS Trims Pfizer Price Target, Citing Overestimated Sales and IRA Headwinds

Posted Apr 8 by Two Blokes

UBS reduced its price target on Pfizer (NYSE:PFE) to $24 from $28, maintaining a Neutral rating as the firm hi

Source: Two Blokes Trading